Muxiang Zhou

ORCID: 0000-0002-2058-1645

Also affiliated with Center for Cancer and Blood Disorders, Children's Healthcare of Atlanta

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Discovery of N-(3,4-Dimethylphenyl)-4-(4-isobutyrylphenyl)-2,3,3a,4,5,9b-hexahydrofuro[3,2-c]quinoline-8-sulfonamide as a Potent Dual MDM2/XIAP Inhibitor”.

Discovery of N-(3,4-Dimethylphenyl)-4-(4-isobutyrylphenyl)-2,3,3a,4,5,9b-hexahydrofuro[3,2-c]quinoline-8-sulfonamide as a Potent Dual MDM2/XIAP Inhibitor

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.0c00932

N/A

0DataRank · unranked

16 citations

Lubing Gu, Sicheng Zhang, Tao Liu, Pradeep B. Lukka, Bernd Meibohm +4 more

Synthesis and biological evaluation of dual MDM2/XIAP inhibitors based on the tetrahydroquinoline scaffold

European Journal of Medicinal Chemistry(2023)10.1016/j.ejmech.2023.115423

N/A

0DataRank · unranked

7 citations

Yang Xie, Tao Liu, Rui Wang, Lubing Gu, Muxiang Zhou +3 more